Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02AYI
|
|||
Former ID |
DNC009583
|
|||
Drug Name |
2-(4-phenoxyphenoxy)ethanamine
|
|||
Synonyms |
2-(4-phenoxyphenoxy)ethanamine; CHEMBL472386; 2-(4-Phenoxyphenoxy)Ethylamine; 72490-14-3; SCHEMBL9486899; SCHEMBL4653229; CTK2H2396; DTXSID40452640; FBLANPWAVFBRNS-UHFFFAOYSA-N; 2-[(p-phenoxy)phenoxy]ethylamine; Ethanamine, 2-(4-phenoxyphenoxy)-; ZINC11945831; BDBM50246062
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H15NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCN
|
|||
InChI |
1S/C14H15NO2/c15-10-11-16-12-6-8-14(9-7-12)17-13-4-2-1-3-5-13/h1-9H,10-11,15H2
|
|||
InChIKey |
FBLANPWAVFBRNS-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 72490-14-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Group IIA phospholipase A2 (GIIA sPLA2) | Target Info | Inhibitor | [1] |
Leukotriene A-4 hydrolase (LTA4H) | Target Info | Inhibitor | [2] | |
BioCyc | Phospholipases | |||
Leukotriene biosynthesis | ||||
KEGG Pathway | Glycerophospholipid metabolism | |||
Ether lipid metabolism | ||||
Arachidonic acid metabolism | ||||
Linoleic acid metabolism | ||||
alpha-Linolenic acid metabolism | ||||
Metabolic pathways | ||||
Ras signaling pathway | ||||
Vascular smooth muscle contraction | ||||
Pancreatic secretion | ||||
Fat digestion and absorption | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
Pathway Interaction Database | Glypican 1 network | |||
Reactome | Acyl chain remodelling of PC | |||
Acyl chain remodelling of PE | ||||
Acyl chain remodelling of PI | ||||
WikiPathways | Cardiac Hypertrophic Response | |||
Glycerophospholipid biosynthesis | ||||
Glycerophospholipid Biosynthetic Pathway | ||||
Spinal Cord Injury | ||||
Eicosanoid Synthesis | ||||
MicroRNAs in cardiomyocyte hypertrophy | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. J Med Chem. 2008 Dec 25;51(24):7882-8. | |||
REF 2 | Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6549-52. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.